Rocket Lab Is Down 57%-Analysts Still See 49% Upside. Is This Fear an Opportunity or a Value Trap?

The Gap Between Price and Wall Street Targets Is the Whole Debate

A 57% decline put Rocket Lab near $63.91, even as Wall Street's average targets still hover around $114.33 to $116.57.

That spread is the core tension. At current levels, the stock looks like a broken story. At the analyst targets, it still looks like a business that could be much larger than what investors see today.

The bearish read: the market is demanding proof, not promise

The stock is still roughly 58% below its 52-week high of $151, and was recently 55% off its May 27 peak. Bears see that drawdown and argue the market is not reacting arbitrarily. After years of paying up for space ambition, investors now want clearer proof that growth, financing, and execution can line up.

Financing is the main pressure point. The Iridium deal requires $3.6 billion in bridge financing, and that has reopened the oldest fear around high-multiple space stocks: dilution could outrun the business's ability to absorb it. In that view, the selloff is not just sector-wide risk aversion. It is the market demanding better math.

The Bull Case Depends on a Different Business - Not the One Rocket Lab Is Today

Bulls are not underwriting Rocket Lab strictly as a launch and parts supplier. They are underwriting the company the Iridium deal could become.

Why the strategic logic is real

If the transaction closes, Rocket Lab is not only adding a major customer or a new contract book. It would combine its launch and satellite manufacturing business with Iridium's global network and spectrum. The deal also promises material revenue scale and could change the mix and stability of Rocket Lab's future cash flows.

That matters because launch revenue is inherently lumpy, while satellite services can provide a more repeatable revenue stream. The bull case is not simply that Rocket Lab could launch more rockets. It is that the company could own more of the space stack, from vehicle construction and launch into a broader operating network.

Why valuation logic changes if the deal works

If the acquisition comes together, Rocket Lab is no longer just a launch company with space-systems exposure. It would also inherit an operating satellite network. That makes the valuation debate more complicated, because investors would no longer be paying only for launch cadence or backlog growth.

The business logic is further supported by government-work momentum. Recent reporting pointed to about $663 million in Space Force contracts and a role in a $17 billion Space Force ceiling agreement. Those wins do not prove the merged model is here yet, but they do suggest Rocket Lab already has exposure to defense demand and larger infrastructure-style programs.

Why the market is still hesitant

Timing is the problem. The deal is expected to be completed in mid-2027, which means investors are being asked to fund the dream before they can own the result. In the meantime, concerns over share dilution and the size of the financing package remain very visible.

That is why the upside can still exist after such a sharp selloff, but it is upside tied to a future version of the company. If integration slips, financing becomes more burdensome than expected, or operating improvements do not arrive quickly enough, the market may keep valuing Rocket Lab as a pre-deal stock.

What Earnings Need to Show for the Bull Case to Hold

The price gap does not have to close tomorrow. But recent market moves show what investors will no longer forgive: vague answers on financing, weak conversion of contracts into revenue, or signs that execution is drifting.

The near-term scorecard

Rocket Lab entered the second quarter with $2.2 billion in backlog and more than $2 billion in liquidity. That gives the company time. It does not, by itself, prove the business model is becoming more durable.

Rocket Lab reports second-quarter results on August 10 after the close. The key questions are straightforward: - Are contract wins turning into visible revenue progress? - Is the liquidity cushion still strong enough to support growth, Neutron development, and M&A activity? - Is management making measurable progress toward profitability?

Recent market discussion has already centered on whether contract wins are translating into revenue growth, so this report matters because it may either calm those concerns or confirm them.

Why the market reacted so harshly before

After Piper Sandler initiated coverage with a Neutral rating, shares fell 11.7% in the afternoon session as investors focused on dilution risk and the $3.6 billion bridge-financing requirement tied to the Iridium deal. That reaction showed what the market cares about most right now.

There is still a positive case. Recent reporting highlighted a $397 million Space Force contract and continued launch reliability with the 92nd Electron mission. But near-term upside now depends less on another operational milestone and more on whether management can convince investors that the financial model is tightening, not loosening.

What would strengthen the cautious-bullish case - and what would break it

If management shows that backlog is converting into revenue and that liquidity remains intact, fear may start to look more like a positioning opportunity.

If results suggest the business still needs too much outside capital before the Iridium-style strategy is tangible, the value-trap argument will get harder to dismiss.